Home

Wednesday, July 30, 2014

WTC2014 | A Phase I/II Placebo-Controlled Trial of C1 Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients


WTC2014 | A Phase I/II Placebo-Controlled Trial of C1 Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients

WTC2014 | A Phase I/II Placebo-Controlled Trial of C1 Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients

Powered by EventPilot



Enviado desde mi iPad
Shared by Unknown en 10:45 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)